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Damage to the locus ceruleus has been implicated in the pathogenesis of a number of neu-
rological conditions. Locus ceruleus neurons accumulate toxic metals such as mercury
selectively, however, the presence of toxic metals in locus ceruleus neurons of people of dif-
ferent ages, and with a variety of disorders, is not known. To demonstrate at what age toxic
metals are first detectable in the locus ceruleus, and to evaluate whether their presence is
more common in certain clinicopathological conditions, we looked for these metals in 228
locus ceruleus samples. Samples were taken at coronial autopsies from individuals with a
wide range of ages, pre-existing conditions and causes of death. Paraffin sections of pons
containing the locus ceruleus were stained with silver nitrate autometallography, which indi-
cates inorganic mercury, silver and bismuth within cells (termed autometallography-
detected toxic metals, or AMG™). No locus ceruleus AMG neurons were seen in 38 individ-
uals aged under 20 years. 47% of the 190 adults (ie, aged 20 years and over) had AMG
locus ceruleus neurons. The proportion of adults with locus ceruleus AMG neurons
increased during aging, except for a decreased proportion in the 90-plus years age group.
No differences were found in the proportions of locus ceruleus AMG neurons between
groups with different neurological, psychiatric, or other clinicopathological conditions, or
among various causes of death. Elemental analysis with laser ablation-inductively coupled
plasma-mass spectrometry was used to cross-validate the metals detected by AMG, by
looking for silver, gold, bismuth, cadmium, chromium, iron, mercury, nickel, and lead in the
locus ceruleus of ten individuals. This confirmed the presence of mercury in locus ceruleus
samples containing AMG neurons, and showed cadmium, silver, lead, iron, and nickel in the
locus ceruleus of some individuals. In conclusion, toxic metals stained by AMG (most likely
inorganic mercury) appear in locus ceruleus neurons in early adult life. About half of adults
in this study had locus ceruleus neurons containing inorganic mercury, and elemental analy-
sis found a range of other toxic metals in the locus ceruleus. Locus ceruleus inorganic mer-
cury increased during aging, except for a decrease in advanced age, but was not found
more often in any single clinicopathological condition or cause of death.
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Introduction
The locus ceruleus supplies noradrenaline to the central nervous system, by which it influences
neuronal and glial function and maintains the blood-brain barrier [1]. The locus ceruleus
plays a role in cognition [2], response to stressors [3], neuroinflammation [4], and in the con-
trol of impulsivity [5]. Damage to the locus ceruleus with loss of its neurons has been impli-
cated in autopsy studies of conditions as diverse as aging [6], Alzheimer disease [2], Parkinson
disease [1], depression [7], bipolar disorder [8], schizophrenia [9] and the sudden infant death
syndrome [10]. Recent structural and functional imaging studies have confirmed a loss of
locus ceruleus neurons during life in aging and Alzheimer and Parkinson diseases, and have
shed light on how decreased noradrenaline leads to changes in locus ceruleus connections that
can explain cognitive changes in these conditions [11,12].
The underlying cause of damage to the locus ceruleus that contributes to these various dis-
orders remains unknown, though it has been hypothesised that a selective uptake of environ-
mental toxicants into the locus ceruleus could be the culprit, possibly combined with genetic
susceptibility to these toxicants [13]. Mercury is a toxicant suspected to play a part in disorders
such as Alzheimer disease [14], Parkinson disease [15] and amyotrophic lateral sclerosis [16],
and mercury is taken up selectively by the locus ceruleus [17]. Mercury is an attractive candi-
date for these disorders since humans worldwide are exposed to mercury, particularly via fish
consumption and mercury-containing dental restorations [18,19], and mercury has actions
that are injurious to cells, the immune system and genes [19].
Although toxic metals have been found in locus ceruleus neurons in patients with Alzhei-
mer disease [20] and amyotrophic lateral sclerosis [17,21], it is not clear to what extent these
metals are present in the locus ceruleus in other disorders, or at what age they start appearing
in the locus ceruleus. It is difficult to assess the contribution of toxic metals to neurodegenera-
tive disorders because neuronal loss is severe by the time brain tissue becomes available via
autopsy. We therefore examined locus ceruleus neurons for toxic metals in people who had
had Australian coronial autopsies (similar to the USA medical examiner system). This gave us
the opportunity to estimate at what age toxic metals first become detectable in the locus ceru-
leus, to examine toxins in the locus ceruleus in a wide range of clinicopathological disorders
and causes of death, and to look for reasons for the variability of toxic metal uptake into the
locus ceruleus between individuals. The histochemical technique of autometallography was
used to look for toxic metals; this demonstrates inorganic mercury, but can also show silver
and bismuth. To validate which autometallography-detected metals were likely to be present,
we used laser ablation-inductively coupled plasma-mass spectrometry to look for mercury, sil-
ver, and bismuth, as well as other toxic metals, in the locus ceruleus in a subset of individuals.
Materials and methods
Study design
The prevalence of AMG™-detected toxic metals in the human locus ceruleus has previously
been estimated in amyotrophic lateral sclerosis [21], Alzheimer disease [20] and autism [22],
and in small numbers of older adults without neurological disease [20,21]. These samples,
however, were not suitable to estimate the prevalence of locus ceruleus toxic metals within a
more general population of varying ages. With the decline in numbers of hospital autopsies, it
is difficult to get access to autopsy brain tissue from people with a wide range of ages who have
died from a variety of conditions, so we sourced tissue samples from coronial autopsies. Aus-
tralian coroners investigate sudden and unexpected deaths to determine the identity of the
deceased, and circumstances and medical causes of death, and an autopsy is ordered by the
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coroner to ensure that balanced, accurate findings regarding the cause of death can be deliv-
ered (http://www.coroners.justice.nsw.gov.au). Our primary aim was to obtain locus ceruleus
samples for analysis of toxic metals from at least 10 people in each decade of life, with a mix-
ture of clincopathological conditions and causes of death within each decade. Our second aim
was to see if any groups of people numbering 10 or more, with various clinicopathological con-
ditions or causes of death (cases), were more likely to have toxic metals in their locus ceruleus
than groups with no known pre-mortem conditions, or undetermined and sudden causes of
death (controls). A third aim was to look for any common factors among people who had high
levels of locus ceruleus toxic metals to try to understand why these people had a particular pre-
dilection to accumulate toxic metals in their locus ceruleus.
Autopsy reports between 1997 and 2014 from the New South Wales Department of Foren-
sic Medicine were examined to find individuals in whom the locus ceruleus had been exam-
ined microscopically. To ensure that a varied sample of the coronial population was studied,
these reports were filtered to select a variety of clinicopathological conditions, such as a history
of incarceration, cancer, neurodegenerative disorder (eg, Alzheimer or Parkinson disease) or
psychiatric disorder (eg, depression or schizophrenia). Further samples were chosen from
individuals who had died from sudden non-medical causes of death, eg, drowning, suicide or
trauma. Cases were collected until ethics-approved numbers for age decades, individual clini-
copathological conditions, and causes of death were reached. Neurodegenerative disorders
were confirmed on neuropathological examination of brains. Brain and body weights, and
body heights, were recorded when available. A total of 228 individuals were studied, with num-
bers of individuals in successive age ranges being 28 (0–9 years), 10 (10–19 years), 27 (20–29
years), 45 (30–39 years), 32 (40–49 years), 11 (50–59 years), 18 (60–69 years), 16 (70–79 years),
14 (80–89 years) and 27 (90-plus years). Adults were defined as those aged 20 years and over.
Ethics
This study, "The role of the locus ceruleus in disorders of the nervous system" (X14-029), was
approved by the Human Research Committee, Sydney Local Health District (RPAH Zone),
and by the Office of the New South Wales Coroner. The institutional review board waived the
need for written informed consent from relatives of individuals studied since this was a de-
identified retrospective study of autopsy tissue.
Tissue sectioning and autometallography
Seven μm paraffin sections of pons containing the locus ceruleus from all 228 individuals, and
in 65 of these individuals (including 39 adults) the midbrain containing the substantia nigra,
were stained for inorganic mercury, silver and bismuth bound to sulphides or selenides, with
silver nitrate autometallography (AMG), an amplification technique that can detect only a few
atoms of these metals within tissues, including the human brain [23,24]. Briefly, sections were
placed in physical developer containing 50% gum arabic, citrate buffer, hydroquinone and sil-
ver nitrate at 26˚C for 80 min in the dark then washed in 5% sodium thiosulphate to remove
unbound silver. Sections were counterstained with mercury-free Improved Harris hematoxy-
lin and viewed with bright-field microscopy. Each staining run included a positive control sec-
tion of mouse spinal cord with motor neuron cell bodies containing mercury following an
intraperitoneal injection of 2 μg/g mercuric chloride [25]. Sections were also stained with
hematoxylin and eosin, and hematoxylin alone, to assess general pathology. Selected pons sec-
tions were immunostained, after AMG staining, with mouse anti-human CD31 monoclonal
antibody (Dako) at 1:100 visualised with Bond Polymer Refine Red to assess the capillary den-
sity within the locus ceruleus, and rabbit anti-human glial fibrillary acidic protein polyclonal
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antibody (Dako) at 1:2000 visualised with diaminobenzidine tetrahydrochloride to see if AMG
was present in locus ceruleus astrocytes.
Numbers of locus ceruleus AMG neurons were counted using a 10x10 eyepiece grid viewed
at 400x magnification, with right and lower exclusion margins, and stepped sequentially
throughout one transverse section of the locus ceruleus [21]. An AMG-stained neuron (ie, an
“AMG neuron”) was defined as any locus ceruleus neuron with a minimum diameter of 26 μm
(the length of one grid square) that contained 10 or more black AMG grains. The proportion
of AMG neurons within the locus ceruleus was then classified as either grade 0 (none), grade I
(1–10%), grade II (11–50%) or grade III (>50%). To assess the biological significance of toxic
metals in the locus ceruleus, individuals with locus ceruleus samples containing 0–10% of
AMG neurons (grades 0 and I) were deemed to be in a “low category” as regards toxic metals,
while those with>10% of AMG neurons (grades II and III) were deemed to be in a “high
category”.
Laser ablation-inductively coupled plasma-mass spectrometry
Seven μm paraffin sections of ten pons samples containing the locus ceruleus (seven male and
three female, six with negative AMG and four with grade III AMG) were deparaffinised and
subjected to LA-ICP-MS analysis [26] for the three metals stained by AMG (inorganic mer-
cury, silver and bismuth), other toxic metals (gold, cadmium, chromium and lead) and the
trace metals iron and nickel. Imaging was performed using a New Wave Research UP213
(Kennelec Scientific, Mitcham, Victoria, Australia) Nd:YAG laser system with a two-volume
large format cell connected to an Agilent 7500cx ICP-MS (Agilent Technologies, Mulgrave,
Victoria, Australia). The ICP-MS was fitted with ‘s’ lenses for enhanced sensitivity and argon
was used as the carrier gas. LA-ICP-MS conditions were optimised on NIST 612 Trace Ele-
ment in Glass CRM and the sample was ablated with a 55 μm spot size and a scan speed of
220 μm s-1 at a frequency of 20 Hz. The data were collated into a single image file using in-
house developed software and visualised using Paraview. Limits of detection using LA-ICP-MS
are estimated to be between 0.05 and 0.81 μg per g [27].
Statistical analyses
GraphPad Prism 7 software was used for unpaired t-tests to look for differences between
means of normally distributed continuous variables, chi-square 2x2 analyses with Fisher’s
exact tests to look for associations between two categorical variables when all cell numbers
were5, and chi-square tests for trend to analyse locus ceruleus toxic metals in relation to age.
Significance was assessed at the 0.05 level.
Results
General pathology
Locus ceruleus neurons, most containing neuromelanin, were found in the posterolateral
aspect of the rostral pons. At least one large thin-walled blood vessel was usually present within
or adjacent to the locus ceruleus (Fig 1A). Capillary density in the locus ceruleus appeared to
be slightly increased compared to surrounding regions (Fig 1A and 1B). In individuals with
Alzheimer or Parkinson diseases a marked loss of locus ceruleus neurons was seen, with
numerous collections of macrophage-bound and free neuromelanin pigment either with or
without AMG (Fig 1C). In older individuals, some neuromelanin was often present in the neu-
ropil in the absence of obvious locus ceruleus neuronal loss. In conditions other than neurode-
generations, locus ceruleus neuronal numbers and densities appeared to be within normal
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Fig 1. Normal appearance and pathology of the locus ceruleus. (A) The locus ceruleus (LC, outlined) contains
numerous, mostly neuromelanin-containing, neuronal cell bodies. White matter (WM) is present at the right, and the
central grey of the pons (CGP) at the left. A large thin-walled blood vessel (closed arrow), probably a post-capillary
venule, is seen within the locus ceruleus. A mesencephalic trigeminal neuron is seen in the upper right corner (open
arrow). Hematoxylin and eosin, Bar = 100 μm. (B) The capillary density in the locus ceruleus is slightly increased,
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limits, though no formal quantitation was undertaken since the pons had not been sampled at
the same transverse level in each person.
Autometallography
Locus ceruleus neuronal AMG. Normal locus ceruleus neurons without AMG (grade 0)
contained yellow-brown granules of neuromelanin (Fig 2A). In grade I, fewer than 10% of
locus ceruleus AMG neurons were seen (Fig 2B); in grade II, 11–50% of locus ceruleus neurons
stained with AMG (Fig 2C); in grade III, more than 50% of locus ceruleus neurons stained
with AMG (Fig 2D). The intensity of AMG varied between neurons of the same individual,
and admixtures of non-stained, lightly-stained and heavily-stained neurons were present in
most people (Fig 2C). Both neuromelanin-containing and non-pigmented locus ceruleus neu-
rons contained AMG, though when neurons were stained heavily with AMG it was not possi-
ble to tell if underlying neuromelanin was present.
Locus ceruleus capillary-associated AMG. Small dense particulate AMG was seen associ-
ated with capillaries in about 20% of adult locus ceruleus samples. These particles were adja-
cent to cell nuclei that had either oval (probably endothelial cell) or round (probably pericyte)
profiles (Fig 3A and 3B). Some AMG was aggregated into mulberry-like clusters. The presence
of this AMG did not correlate closely with the presence of locus ceruleus AMG neurons, ie, it
could be present when no locus ceruleus AMG neurons were seen, and absent when locus
ceruleus AMG neurons were abundant. No other region of the pons contained these particles.
AMG in other cells. No AMG was seen within glial fibrillary acid protein-immunostained
astrocytes in the locus ceruleus. Occasional scattered neurons in the pontine reticular formation
and dorsal raphe nuclei contained AMG, usually in sections in which locus ceruleus grade III
AMG was present. No AMG was seen in other pontine neurons, eg, in the mesencephalic
nucleus of the trigeminal nerve immediately dorsolateral to the locus ceruleus (Fig 1A). One
individual with Parkinson disease had widespread neuronal staining with AMG, which also
affected locus ceruleus and substantia nigra neurons. No substantia nigra neurons contained
AMG in any of the other 38 adults in whom the midbrain was sampled (despite 16 of these
having locus ceruleus AMG neurons), nor in any of the 26 individuals aged less than 20 years.
Perivascular neurons in pontine basal nuclei contained non-specific (ie, seen on all stains)
multiple small dark-brown birefringent particulate cytoplasmic bodies in some sections, of
undetermined nature.
Age and locus ceruleus AMG. No locus ceruleus AMG neurons were seen in the 38
infants and adolescents under the age of 20 years. In the 190 adults aged20 years, a total of
53% had grade 0, 13% grade I, 18% grade II, and 16% grade III AMG. All four grades of AMG
were present in each adult age decade (Fig 4).
The proportion of people with any locus ceruleus neuronal AMG increased from none
between the ages of 0 and 19 years, to a low level in the third decade (22%), then plateaued at a
moderate level between the ages of 30 and 60 years (44–50%), followed by a higher plateau
between the ages of 60 and 90 years (56–67%), before falling back to a moderate level from the
age of 90 years on (44%) (Fig 5, chi-square trend for aging 21.9, p<0.0001).
compared to adjacent white matter (WM), as seen by the red-immunostained capillary endothelial cells (some
asterisked). Black AMG grains are present in several locus ceruleus neurons (one with arrow). AMG/hematoxylin/
CD31, Bar = 50 μm. (C) This locus ceruleus has a reduced density of neurons. Free and macrophage-bound
neuromelanin originating from destroyed locus ceruleus neurons is prominent, with this pigment having either AMG
(closed arrow) or no AMG (open arrow). Some remaining locus ceruleus neurons either with (asterisks) or without
AMG are seen. AMG/hematoxylin, Bar = 20 μm.
https://doi.org/10.1371/journal.pone.0203627.g001
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Fig 2. Grades of AMG in the locus ceruleus. (A) Grade 0. No black AMG grains are seen in these locus ceruleus neurons that
contain yellow-brown cytoplasmic neuromelanin granules. (B) Grade I. One (ie, fewer than 10%) of these locus ceruleus neurons
(closed arrow) contains AMG. Free and macrophage-bound neuromelanin pigment (without AMG, open arrow) is seen in the
neuropil. (C) Grade II. Two locus ceruleus neurons (arrows, 10–50%) stain with AMG. (D) Grade III. More than 50% of locus
ceruleus AMG neurons are present. The intensity of staining varies between neurons, with a heavily-stained neuron (closed arrow)
adjacent to a non-stained neuron (open arrow). AMG is also present in scattered free and macrophage-bound neuromelanin. All
figures AMG/hematoxylin, Bars = 20 μm.
https://doi.org/10.1371/journal.pone.0203627.g002
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Fig 3. Capillary-associated AMG in the locus ceruleus. (A) Small punctate or larger mulberry-shaped black AMG
deposits are present in and around capillary walls. Small deposits can be identified adjacent to oval (endothelial cell,
closed arrow) or round (pericyte, open arrow) nuclei, or in capillary walls (asterisk). No neuronal AMG is present. (B)
More extensive mulberry AMG deposits are seen in a locus ceruleus with numerous AMG neurons (one with asterisk).
Small AMG deposits can be seen adjacent to endothelial cell (closed arrow) or pericyte (open arrow) nuclei. Both figures
AMG/hematoxylin, Bar = 20 μm.
https://doi.org/10.1371/journal.pone.0203627.g003
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Clinicopathological diagnoses and locus ceruleus AMG. Comparisons between low and
high category locus ceruleus AMG in adult locus ceruleus samples in different clinicopatholog-
ical groups can be seen in Table 1. Only the combined neurodegeneration group had a signifi-
cantly higher proportion of high level AMG compared to a control group with no known pre-
mortem conditions, but this could have been because the mean age of the neurodegeneration
group (77 years) was higher than that of the control group (55 years). Individuals with locus
ceruleus grade III AMG neurons were present in all clinicopathological conditions when case
Fig 4. Grades of locus ceruleus AMG and increasing age. A mixture of all four grades of locus ceruleus AMG was found in all adult
age decades.
https://doi.org/10.1371/journal.pone.0203627.g004
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numbers were10. The combined psychiatric disorder group was similar to the control group
as regards low and high locus ceruleus AMG levels.
No pre-mortem clinicopathological conditions were identified in the 28 individuals aged
<10 years (14 male, 14 female). Two of the 10 individuals aged 10–19 years (7 male, 3 female)
had a history of epilepsy.
Causes of death and locus ceruleus AMG. Comparisons between low and high category
locus ceruleus AMG among various causes of death in adults can be seen in Table 2. No statis-
tically-significant differences in numbers of people with these levels of AMG within the locus
ceruleus was found for any groups of causes of death, using the Undetermined and sudden
causes of death as a control group. Neither the combined medical nor combined non-medical
causes of death groups showed differences in locus ceruleus AMG compared to the control
group. Individuals with grade III AMG were found in all causes of death groups when case
numbers were10.
Causes of death in the 28 individuals aged<10 years were the sudden infant death syn-
drome (N = 20), trauma (N = 5) and drowning (N = 3). In the 10 individuals aged 10–19 years
causes of death were trauma (N = 4), undetermined (N = 2) and one each of drowning, drug
overdose, suicide and respiratory.
Gender and locus ceruleus AMG. Adult males (N = 124, mean 49.5 y, SD 22.1 y, range
20–100 y) were on average younger than adult females (N = 66, mean 64.1 y, SD 268 y, range
20–104 y) (difference between means 14.6 y, 95% CI 7.4–21.8 y, p<0.0001). The proportions
of adults with different grades of locus ceruleus AMG did not differ between males and females
Fig 5. Proportions of people with any locus ceruleus AMG and increasing age. The proportion of people with any locus ceruleus
neuronal AMG increased from the third decade onwards, but with a decrease in the final 90-plus years age range.
https://doi.org/10.1371/journal.pone.0203627.g005
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on Fisher’s exact testing. Proportions for males and females respectively were grade 0: 53.2%
and 53.0% (p = 0.99), grade I: 15.3% and 7.6% (p = 0.17), grade II: 19.4% and 16.7% (p = 0.70)
and grade III: 12.1% and 22.7% (p = 0.06). The tendency for Grade III to be more common in
females was probably because there were more older females.
Brain weight, body mass index and locus ceruleus AMG. Brain weights of adults did not
differ significantly between low category (N = 125, mean 1366 g, SD 185 g, range 830–1880 g)
and high category (N = 65, mean 1351 g, SD 181 g, range 1002–1790 g) locus ceruleus AMG
groups (p = 0.58). Adult body mass index did not differ significantly between low category
(N = 117, mean 25.8, SD 7.5, range 10–52) and high category (N = 64, mean 25.9, SD 8.7, range
9–61) locus ceruleus AMG groups (p = 0.92). There are fewer numbers in these groups since
body heights were not always available to calculate body mass index.
Laser ablation-inductively coupled plasma-mass spectrometry
(LA-ICP-MS)
Mercury was detected on LA-ICP-MS in the locus ceruleus of all four individuals in whom
locus ceruleus neurons were stained with AMG (Table 3, Fig 6A). No LA-ICP-MS mercury
Table 1. Clinicopathological conditions of adults with low (grades 0 and I) or high (grades II and III) categories and grade III alone, of locus ceruleus AMG.
Clinicopathological
condition
Low category locus ceruleus AMG N
(%)
High category locus ceruleus AMG N
(%)
Chi-square p Grade III locus ceruleus AMG
N
Anorexia nervosa 0 (0) 1 (100) - 1
Bipolar disorder 4 (44) 5 (56) - 3
Cancer 3 (75) 1 (25) - 0
Crime 23 (85) 4 (15) - 1
Dementia—Alzheimer 11 (65) 6 (35) 0.75 2
Dementia—FTD 0 (0) 1 (100) - 0
Dementia—Lewy body 4 (80) 1 (20) - 0
Dementia—NOS 3 (75) 1 (25) - 1
Depression 6 (67) 3 (33) - 2
Down syndrome 1 (100) 0 (0) - 0
Epilepsy 1 (33) 2 (67) - 0
Huntington disease 0 (0) 1 (100) - 1
MSA 1 (25) 3 (75) - 1
Myotonic dystrophy 0 (0) 1 (100) - 1
Neurodegenerative disorders 30 (51) 29 (49) 0.045 10
None known (Controls) 32 (71) 13 (29) NA 6
Obesity 3 (100) 0 (0) - 0
Parkinson disease 11 (55) 9 (45) 0.25 5
PSP 0 (0) 1 (100) - 0
PTSD 2 (100) 0 (0) - 0
Psychiatric disorders 28 19 0.28
Schizophrenia 18 (62) 11 (38) 0.45 5
Stroke 1 (50) 1 (50) - 1
Substance abuse 1 (100) 0 (0) - 0
-: cell number less than 5; AMG: toxic metal autometallography; Controls: used as control for chi-square testing; FTD: frontotemporal dementia; MSA: multiple system
atrophy; NA: not applicable; Neurodegenerative disorders: sum of Dementia, Huntington disease, Myotonic dystrophy, MSA, Parkinson disease and PSP; NOS: not
otherwise specified; PSP: progressive supranuclear palsy; Psychiatric disorders: sum of Bipolar disorder, Depression and Schizophrenia; PTSD: post-traumatic stress
disorder.
https://doi.org/10.1371/journal.pone.0203627.t001
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was found in five of the six individuals with no locus ceruleus AMG. In one individual,
LA-ICP-MS mercury was detected in the locus ceruleus in the absence of AMG, indicating this
was likely to be organic mercury (which is not detectable on AMG). LA-ICP-MS-detected
inorganic mercury was therefore the only metal consistently correlated with AMG (Table 3).
Cadmium (Cd) was present in the locus ceruleus of all ten people (Fig 6, Table 3). Both iron
Table 2. Causes of death in adults who had low (grades 0 and I) or high (grades II and III) categories, or grade III alone, of locus ceruleus AMG.
Cause of death Low category locus ceruleus AMG N (%) High category locus ceruleus AMG N (%) Chi-square p Grade III locus ceruleus AMG N
Asphyxia 4 (44) 5 (56) - 0
Cancer 2 (67) 1 (33) - 0
Cardiovascular 15 (54) 13 (46) 0.35 7
Cirrhosis 1 (100) 0 (0) - 0
Controls 37 (65) 20 (35) NA 10
Drown 14 (78) 4 (22) - 3
Drug overdose 13 (68) 6 (32) >0.99 3
Homicide 1 (25) 3 (75) - 1
Hypothermia 1 (100) 0 (0) - 0
Infection 9 (64) 5 (36) >0.99 4
Medical conditions 33 (63) 19 (37) >0.99 11
Non-medical conditions 85 (68) 40 (32) 0.73 18
Respiratory 1 (100) 0 (0) - 0
Stroke 4 (100) 0 (0) - 0
SUDEP 2 (67) 1 (33) - 0
Suicide 36 (73) 13 (27) 0.40 5
Trauma 16 (64) 9 (36) - 5
Undernutrition 0 (0) 1 (100) - 1
Undetermined 6 (60) 4 (40) - 1
-: cell number less than 5; AMG: toxic metal autometallography; Controls: combined Drown, Homicide, Trauma and Undetermined used as control for chi-square
testing; Medical conditions: sum of cancer, cardiovascular, cirrhosis, infection, respiratory, stroke and SUDEP; NA: not applicable; Non-medical conditions: all except
Medical conditions and Undetermined; SUPDEP: sudden unidentified death in epilepsy.
https://doi.org/10.1371/journal.pone.0203627.t002
Table 3. LA-ICP-MS analyses of metals in the posterior pons of individuals either with or without locus ceruleus AMG.
Decade y Condition AMG Hg Ag Bi Au Cd Cr Fe Ni Pb
30–39 Bipolar Positive + - - - + - - G - G - G
>90 Aged Positive + - - - + - - G - G - G
20–29 Huntington Positive + + - - + - - G - G - S
60–69 Drown Positive + + - - + - + G + G + G
50–59 Drown Negative - - - - + - - G - G - G
50–59 Schizophrenia Negative - + - - + - - G - G - W
60–69 Drown Negative ^ + + - - + - + G + G - S
40–49 Drown Negative - + - - + - - G + G - W
40–49 Schizophrenia Negative ^ - + - - + - - G - G + S
40–49 Schizophrenia Negative - + - - + - + G - G - S
Positive: Grade III AMG in locus ceruleus, Negative: no AMG in locus ceruleus, ^: locus ceruleus capillary-associated AMG; +: metal present in locus ceruleus, -: metal
not present in locus ceruleus, G: metal present in grey matter, S: metal present in subpial and periventricular pons, W: metal widespread in grey and white matter.
https://doi.org/10.1371/journal.pone.0203627.t003
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Fig 6. LA-ICP-MS of the posterior pons of individuals with either positive or negative locus ceruleus AMG. Sections stained
with AMG and Luxol-fast blue for myelin (at the top of the figure) show the position of the locus ceruleus (within dashed circles) in
the posterior pons. (A) A 20–29 year-old with Huntington disease and locus ceruleus AMG (Table 3) has mercury, silver and
cadmium in the locus ceruleus (situated within the dashed circles) but no iron, lead or bismuth. Iron and nickel are present in the
grey matter, and lead in the subpial pons. (B) A 40–49 year-old with schizophrenia and no locus ceruleus AMG neurons (Table 3)
has silver and cadmium in the locus ceruleus, but no mercury, iron, lead or bismuth above background levels. Iron and nickel are
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(Fe) and nickel (Ni) were seen in the grey matter of the posterior pons (Fig 6), and in three
individuals in the locus ceruleus in amounts above background (Table 3). Silver (Ag) was
found in the locus ceruleus of people both with and without AMG (Fig 6), suggesting this silver
is bound to proteins and so not visible on AMG. In three people, silver was also seen in the
grey matter anterolateral to the silver-containing locus ceruleus (Fig 6A). Lead (Pb) was seen
in the pons of all individuals, either in the grey matter or widespread in the grey and white
matter. In four people, lead was predominantly localised to the subpial surfaces and periventri-
cular region of the pons (Fig 6B), suggesting uptake from the cerebrospinal fluid. Bismuth
(Bi), the third metal that can be detected by AMG, was not seen in the pons of any individuals
(Fig 6), and neither was gold (Au) nor chromium (Cr). In the two individuals who had locus
ceruleus capillary-associated AMG, no pattern of elemental accumulation could explain the
nature of these deposits (Table 3).
Discussion
Key findings in this study are that toxic metals (most likely inorganic mercury) were detected
in about half of adults from a mixed clinicopathological and cause of death population. The
toxic metals started to appear in locus ceruleus neurons after the age of 20 years, and the pro-
portion of people with locus ceruleus toxic metals increased until a decrease in late old age. No
clinicopathological condition or cause of death was statistically associated with the presence of
locus ceruleus AMG-demonstrable toxic metals. Elemental analysis of a subset of individuals
confirmed that inorganic mercury was likely to be the metal responsible for the AMG staining.
For the purposes of discussion, it will therefore be assumed that in most individuals the toxic
metal demonstrated by AMG was inorganic mercury bound to sulfides and selenides, this
being the form of mercury recognised by AMG.
An increase in inorganic mercury in the locus ceruleus with aging could be due to accumu-
lated mercury from mercury-containing dental amalgam restorations, occupational exposure
to inorganic mercury, as well as exposure to organic mercury since methylmercury from fish,
the commonest human source of mercury, is slowly demethylated in the human brain to inor-
ganic mercury [19,28]. Inorganic mercury appears to be the proximate toxic mercury species
in the CNS [29], and the slow accumulation of brain inorganic mercury over years or decades
[30] could account for the late-life onset of neurodegenerative diseases: these could be precipi-
tated when the concentration of inorganic mercury in locus ceruleus neurons reached a neuro-
toxic tipping point [31]. However, deleterious effects of inorganic mercury in the locus
ceruleus would be most likely only if other factors predisposing to neurotoxicity were present,
such as genetic susceptibilities [32], selenium deficiency [33] and synergistic interactions
between mercury and other toxic metals [19,34].
The proportion of people with locus ceruleus inorganic mercury declined in the 90-plus
years age group, decreasing from its heights in the previous three decades. This may be because
those who survived to this advanced age were exposed to insignificant amounts of mercury
throughout their lives and therefore avoided the many diseases associated with mercury toxic-
ity [35]. The lower amount of locus ceruleus inorganic mercury in later life may therefore be
the reason for the reduced incidence in advanced age of Alzheimer disease [36], Parkinson dis-
ease [37] and amyotrophic lateral sclerosis [38], all disorders that have been associated with
exposure to mercury [39]. Less toxic metal content of the locus ceruleus in advanced age could
also underlie the plateau of human mortality in later life that has been described, with death
present in the grey matter, and lead in the subpial and periventricular pons. The linear collection of iron (red, on the right side of the
pons) is in the distribution of a blood vessel and is probably iron in red blood cells. 4V: fourth ventricle. CPS: counts per second.
https://doi.org/10.1371/journal.pone.0203627.g006
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rates levelling off from 105 years and beyond [40], since people who had not been exposed to
toxic metals in early life could be expected to have fewer causes of mortality when older.
Older adults with a high cognitive reserve have higher locus ceruleus neuroimaging signal
intensities than those with a low reserve [41], and arguably less of a tendency to develop Alz-
heimer disease and early death, so they may have lower levels of locus ceruleus toxic metals.
On the other hand, some autopsy studies report a continued loss of locus ceruleus neurons
even in the oldest old [6], so the relationship between aging and changes in locus ceruleus his-
tology and signal intensity remains unclear [42]. An increased neuromelanin signal in the
locus ceruleus in middle age may be due to increased neuromelanin production as a defensive
manoeuvre to bind toxic metals [43]. On the other hand, a decrease in neuromelanin signal
intensity in later life could be due to a loss of locus ceruleus cells caused by prolonged oxidative
damage from, for example, accumulated metals [44]. A potential confounding factor is that
toxic metals such as mercury can reside within neurons in sufficient amounts to cause axonal
shrinkage, but not to destroy the cell body [25], implying that mercury could reduce locus
ceruleus noradrenaline output without causing cell loss.
Inorganic mercury was taken up by the locus ceruleus in only some people in each of the
different clinicopathological and cause of death groups. A clue as to why this is so may be that
various stressors upregulate locus ceruleus activity for prolonged periods of time [45]. So, in
people who are subject to psychological stress at the same time as being exposed to toxic met-
als, stress-activated locus ceruleus neurons could accumulate these metals. This would also
explain the apparently random accumulation of inorganic mercury within locus ceruleus neu-
rons, since if a subset of locus ceruleus neurons were activated by a stressor at the time of toxic
metal exposure, they alone would be the ones to take up the toxic metal. It is therefore of inter-
est that many people who had dense AMG staining of the locus ceruleus also had conditions in
which high levels of psychological stress have been described. These include stressful condi-
tions such as dementia [46], Parkinson disease [47] and schizophrenia [3], as well as stress-
inducing conditions in which there is no reason to suspect that toxic metals plays a primary
role, such as Huntington disease [48] and anorexia nervosa [49]. We unfortunately have no
way of knowing what stressors these individuals were subjected to during life, but this concept
of stress-induced toxin uptake could be explored with animal models.
It is not clear why the locus ceruleus accumulates toxic metals selectively. Rhesus monkeys
have an extensive capillary blood supply to the locus ceruleus [50], but in our study human
locus ceruleus capillary density was only slightly increased compared to surrounding tissue.
Locus ceruleus neurons within individuals varied markedly in inorganic mercury content,
indicating that a high blood flow to the entire locus ceruleus is unlikely to be a major factor
underlying this variable uptake. The locus ceruleus is close to the fourth ventricle and so could
be exposed to toxins in the cerebrospinal fluid [2], but we found that locus ceruleus neurons
close to the fourth ventricle did contain more inorganic mercury than those at a greater dis-
tance from the ventricle. Mercury could also employ a noradrenaline-associated transporter to
enter locus ceruleus neurons, in a similar way the renal tubule mercury transporter operates
[51]. Toxic metals could also enter locus ceruleus neurons via retrograde uptake from the
extensive axonal connections these neurons have with brain microvessels [13]. Finally, mer-
cury could accumulate in locus ceruleus neurons by binding to neuromelanin [52] and not be
available for elimination via the glymphatic or other pathways. However, inorganic mercury
was only rarely seen in neuromelanin-containing cells of the substantia nigra in our study, so
the presence of neuromelanin alone is unlikely to account for the large amounts of mercury
seen in the locus ceruleus.
Several lines of evidence link neurodegenerative disorders with mercury and the locus ceru-
leus. Locus ceruleus neuronal loss is marked in many neurodegenerative disorders in which
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associated losses of noradrenaline have been described [53]. The locus ceruleus is involved
early in Alzheimer disease [54] and people with Alzheimer disease have more inorganic mer-
cury in their locus ceruleus than controls [20]; furthermore, hyperphosphorylated tau is often
found in the human locus ceruleus [54], and mercury causes tau hyperphosphorylation [55]
and aggregation [56]. The normal locus ceruleus may protect the substantia nigra from dam-
age [57] so the locus ceruleus may be the primary site of damage in Parkinson disease [58].
Rotenone has been implicated in Parkinson disease; it is of interest that the locus ceruleus is
more sensitive to the effects of rotenone than the substantia nigra [59], and that rotenone
demethylates methylmercury to more neurotoxic inorganic mercury [60]. Abnormalities in
the locus ceruleus have been described in multiple sclerosis [61], with mercury being suspected
to be an environmental trigger for the disease [62]. Most multiple sclerosis patients present for
the first time in early adulthood [63], the age at which we first saw inorganic mercury appear-
ing in the locus ceruleus.
Inorganic mercury in our study did not appear to be markedly more frequent in the locus
ceruleus of people with neurodegenerative conditions. However, locus ceruleus neuronal loss
is severe in Alzheimer and Parkinson diseases, and the remaining neurons available for
autopsy study could be the ones that never contained inorganic mercury (a "survivor" effect).
Damage to the locus ceruleus has been implicated in psychiatric conditions [64], but we did
not find more inorganic mercury in the locus ceruleus of people with depression, bipolar dis-
order or schizophrenia, either for each individual condition, or when psychiatric diagnoses
were grouped together. We also found no locus ceruleus inorganic mercury in infants who
died from the sudden infant death syndrome, in which a defect in arousal secondary to locus
ceruleus damage has been postulated [10].
The finding of inorganic mercury in the locus ceruleus may be a clue as to why incidences
of several neurological disorders have been either increasing or decreasing over time. This
may be because human exposure to the two major sources of environmental mercury, fish
consumption and mercury-containing dental restorations, are going in different directions.
Rising atmospheric mercury, mostly from burning fossil fuels [65], is converted by aquatic
microorganisms into methylmercury, which is increasingly bioaccumulated by fish consumed
by humans [66]. The rising incidences described for amyotrophic lateral sclerosis [67], Parkin-
son disease [68] and multiple sclerosis [69] could be linked to this increasing exposure to mer-
cury, originating from atmospheric sources. On the other hand, the incidence of Alzheimer
disease appears to be decreasing in a number of countries [70], in parallel with falling exposure
to inorganic mercury from reduced numbers of mercury-containing dental restorations [71].
Further epidemiological studies of mercury exposure in these disorders may cast more light on
this issue.
Mercury within the locus ceruleus could affect noradrenaline output in two opposite ways.
First, oxidative stress caused by mercury [19] could decrease noradrenaline output, with
downstream consequences in particular for Alzheimer and Parkinson diseases [72]. Second,
mercury could paradoxically increase noradrenaline output from the locus ceruleus by binding
to and damaging cysteine-rich enzymes that normally deactivate noradrenaline, such as coen-
zyme S-adenosylmethionine; this is a mechanism proposed for an increase in noradrenaline
output from mercury-containing adrenal medulla ganglion cells that can cause arterial hyper-
tension [73]. Increased noradrenaline output from the locus ceruleus following mercury expo-
sure could therefore also have a bearing on other conditions suspected to involve an increase
in noradrenaline output, such as the post-traumatic stress disorder [74].
Elemental analysis of a subset of individuals showed that other neurotoxic metals apart
from mercury can be taken up selectively by the locus ceruleus. Cadmium was found in the
locus ceruleus of all ten individuals examined, which may not be surprising since cadmium
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exposure is common from widespread environmental sources [75], including cigarette smok-
ing [76]. Cadmium in cigarette smoke taken up by the locus ceruleus may therefore be the rea-
son smoking is linked to the risk of amyotrophic lateral sclerosis [77], Alzheimer disease [78]
and multiple sclerosis [79]. The finding that lead (Pb) in two individuals was localised to sub-
pial and periventricular surfaces exposed to cerebrospinal fluid is of interest, given the finding
that inorganic mercury can also be concentrated in subpial regions and may play a part in the
pathogenesis of the subpial and periventricular demyelinating plaques of multiple sclerosis
[80]. Lead was also seen concentrated in the locus ceruleus in two individuals. Silver was pres-
ent in the locus ceruleus of six of the ten individuals studied; silver is found in dental amalgam
restorations (together with mercury) and is increasingly used in nanoparticles for commercial
and medical applications [81]. The silver in the locus ceruleus was not reliably picked up by
AMG in our study and so was most likely to be in a protein-bound form. The trace elements
iron and nickel were found in grey matter regions of the pons, and three individuals had
increases in iron and nickel in their locus ceruleus. Iron has been linked to a number of neuro-
degenerative disorders [82]. Iron levels increase in the brain throughout life [83] but we could
not estimate an age effect since we did not have quantitative measures of these elements.
Finally, the finding of multiple toxic metals within the locus ceruleus may have pathogenetic
implications since harmful synergistic interactions between toxic metals, as well as between
toxic and essential metals, have been described [19,34].
LA-ICP-MS did no show any consistent pattern of metals in two individuals who had locus
ceruleus capillary-associated AMG. Greater numbers of cases with capillary-associated AMG
will need to be analysed for more metals to assess the chemical makeup of these collections.
Limitations of the study are: (1) Full medical histories and complete results of investigations
were not available, since these were not hospital autopsies. However, major pre-mortem diag-
noses and medications were listed, and full autopsy pathology results were available from all
individuals. (2) The study aimed primarily to look at age as a factor in the uptake of toxins into
the locus ceruleus, so numbers of people with specific diagnoses or causes of death were often
limited. Further investigations of locus ceruleus toxic metals within specific disease subgroups
would best be performed using tissue from disease-specific brain banks. (3) We did not quanti-
tate the metals found within the locus ceruleus, but this is planned as a future project. (4) Coro-
nial autopsy populations, aimed largely at investigating unnatural deaths, are unlikely to
precisely replicate conditions found in general living populations. We attempted to minimise
the differences by studying people with a wide range of disorders, as well as those without
known medical conditions who died suddenly and unexpectedly. Of note, the proportion of
people in this study who had locus ceruleus AMG staining was similar to that of smaller age-
matched brain donor populations who had no neurological disorders [20,21]. (5) The study
was biased towards younger men, since more men than woman have coronial autopsies to
investigate unnatural deaths. The older women in our study tended to have more grade III
locus ceruleus staining than the younger men, but the other grades of staining showed no gen-
der effect, so gender would be unlikely to affect the overall age-related findings of the study.
Conclusions
Toxic metals in the locus ceruleus can be found at autopsy in about half of an adult population
with diverse clinicopathological conditions and causes of death. The toxic metal detected by
autometallography is most likely to be inorganic mercury, which has the potential to damage
locus ceruleus neurons and affect noradrenaline output to the brain. This has potential conse-
quences in particular for neurodegenerative and psychiatric disorders. The proportion of locus
ceruleus neurons containing toxic metals appears to increase throughout adulthood, except for
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a decrease in advanced age. This may underlie why some neurodegenerative disorders have
reduced incidences at advanced ages, and why mortality rates appear to be stable in the older
old. No particular medical condition or cause of death was associated with the amount of inor-
ganic mercury in the locus ceruleus, so other reasons for the variable uptake of this toxic metal
remain to be found. One possibility is that toxins are taken up by a stressor-activated locus
ceruleus.
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